TATVA
Invest with MTF
Invest Now
Invest in Tatva Chintan Pharma Chem with 2.33X leverage
Tatva Chintan Pharma Chem live price: ₹1162. It opened at ₹1,173 vs previous close ₹1,156. The 50 & 200 DMA stand at ₹1,226.68/₹1,178.77.
Tatva Chintan Pharma Chem Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹1,610
- Open Price₹1,173
- Previous Close₹1,156
- Volume56
- 50 DMA₹1,226.68
- 100 DMA₹1,237.31
- 200 DMA₹1,178.77
Investment Returns
- Over 1 Month -2.79%
- Over 3 Month -19.45%
- Over 6 Month + 15.36%
- Over 1 Year + 66.05%
Smart Investing Starts Here Start SIP with Tatva Chintan Pharma Chem for Steady Growth!
Tatva Chintan Pharma Chem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 83
- PEG Ratio
- 0.6
- Market Cap Cr
- 2,718
- P/B Ratio
- 3.5
- Average True Range
- 60.1
- EPS
- 14.01
- Dividend Yield
- 0.1
- MACD Signal
- -21.78
- RSI
- 45.96
- MFI
- 57.61
Tatva Chintan Pharma Chem Financials
Tatva Chintan Pharma Chem Technicals
EMA & SMA
Current Price
₹1,162.00
+
66.4
(6.06%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,179.12
- 50 Day
- ₹1,226.68
- 100 Day
- ₹1,237.31
- 200 Day
- ₹1,178.77
Resistance and Support
1142.93
- R3 1,249.37
- R2 1,209.43
- R1 1,182.87
- S1 1,116.37
- S2 1,076.43
- S3 1,049.87
Tatva Chintan Pharma Chem Corporate Actions - Bonus, Splits, Dividends
Tatva Chintan Pharma Chem F&O
About Tatva Chintan Pharma Chem
- NSE Symbol
- TATVA
- BSE Symbol
- 543321
- Chairman & Managing Director
- Mr. Chintan Nitinkumar Shah
- ISIN
- INE0GK401011
Similar Stocks to Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem FAQs
Tatva Chintan Pharma Chem share price is ₹1,162 As on 11 March, 2026 | 08:48
The Market Cap of Tatva Chintan Pharma Chem is ₹2718.2 Cr As on 11 March, 2026 | 08:48
The P/E ratio of Tatva Chintan Pharma Chem is 83 As on 11 March, 2026 | 08:48
The PB ratio of Tatva Chintan Pharma Chem is 3.5 As on 11 March, 2026 | 08:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.